Among these 7 genes, PRMT3, an arginine methyltransferase ranked as the 6th hit in the CRISPRa screen, drew our attention, because of the critical role of protein arginine methylation in tumor progression and therapeutic resistance22,23. This evidence concerns the gene PRMT3 and neoplasm.